CEO Salary & Executive Compensation
Abbott Laboratories ABT
CEO: Robert Ford · Medical Devices · 114,000 employees
Robert Ford, CEO of Abbott Laboratories (ABT), earned $12.0M in total compensation in 2025. Abbott Laboratories receives a Pay-for-Performance grade of C (63/100), with a CEO-to-worker pay ratio of 133:1 and a say-on-pay shareholder approval of 85.6%. The company's 3-year total shareholder return is +3.2%.
How Abbott Laboratories CEO Pay Compares
Robert Ford's $12.0M total compensation is 0% below the Medical Devices industry median of $12.0M. The 133:1 CEO-to-worker pay ratio is 20% higher than the industry average of 111:1.
Robert Ford, CEO of Abbott Laboratories (ABT), received $12.0M in total reported compensation. The package mix typical at this scale: a small base salary, a larger stock-award component, and performance-tied incentives that vest over multiple years based on relative TSR or earnings benchmarks.
The CEO-to-median-worker pay ratio runs 133x. Lower ratios typically reflect companies with higher-paid workforces (financial services, technology, professional services) where the median worker pay denominator is itself substantial. Three-year performance has been roughly flat — TSR of 3.2% alongside 5.1% revenue growth. Flat performance over a multi-year window is where pay-versus-performance debates get the most heated: large compensation packages without commensurate shareholder returns are the modal complaint at annual meetings.
Shareholders supported the compensation package at 86% on the most recent say-on-pay vote. Solid support without overwhelming endorsement is the typical pattern for established public companies with conventional compensation programs. Abbott Laboratories operates in Medical Devices with 114,000 employees and $40.1B in annual revenue, and currently carries a market capitalization of $210.0B. Pay comparisons across companies require controlling for these structural factors — a $20M package at a $10B-revenue tech company reads differently than the same package at a $1B-revenue industrial.
Source: SEC EDGAR — DEF 14A proxy statements for Abbott Laboratories (ABT).
Compensation Breakdown
Robert Ford's $12.0M total compensation package for fiscal year 2025 includes $1.2M in base salary, $6.0M in stock awards, $1.4M in option awards, and $1.8M in bonus and non-equity incentives.
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2024 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2023 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2022 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Robert Ford, CEO of Abbott Laboratories (ABT), earns $12.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Frequently Asked Questions
Robert Ford, CEO of Abbott Laboratories (ABT), earns $12.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Abbott Laboratories has a Pay-for-Performance Score of C (63/100). The company's 3-year total shareholder return is +3.2%, and the say-on-pay shareholder vote passed with 85.6% approval.
The CEO-to-median-worker pay ratio at Abbott Laboratories is 133:1. The median worker at Abbott Laboratories earns $90K per year, while CEO Robert Ford earns $12.0M in total compensation.
Abbott Laboratories employs approximately 114,000 people. The company operates in the Medical Devices industry within the Healthcare sector, generating $40.1B in annual revenue.